113 results on '"Young, Vincent B."'
Search Results
2. How to develop a controlled human infection model for Clostridioides difficile
3. Virulence and genomic diversity among clinical isolates of ST1 (BI/NAP1/027) Clostridioides difficile
4. A Pilot Study: Transcriptional Profiling, Functional Analysis, and Organoid Modeling of Intestinal Mucosa in Hirschsprung Disease
5. Capturing the environment of the Clostridioides difficile infection cycle
6. Mechanistic insights into consumption of the food additive xanthan gum by the human gut microbiota
7. An improved workflow for accurate and robust healthcare environmental surveillance using metagenomics
8. Comparison of Daily Versus Admission and Discharge Surveillance Cultures for Multidrug-Resistant Organism Detection in an Intensive Care Unit.
9. Public health case for microbiome-sparing antibiotics and new opportunities for drug development.
10. The Relationship Between the Microbiome and Antimicrobial Resistance
11. Lessons learned from the prenatal microbiome controversy
12. 290. Prediction of Severe Clostridioides difficile Infection Using Isolate Genomic Variation Influenced by Patient Comorbidity Score
13. 2956. Increased Microbiota Alpha Diversity is Associated with Decreased Hospital Mortality in Medical Intensive Care Unit Patients
14. 253. Detecting Vancomycin-Resistant Enterococcus (VRE) Gut Colonization in Medical Intensive Care Unit (MICU) Patients: Comparing Culture and Metagenomics
15. 2957. Decreased microbial diversity and baseline intestinal inflammation are associated with worse outcome in aged, female mice infected with Clostridioides difficile
16. 284. Age-related differences in B-cell response during Clostridioides difficile infection in mice
17. Regional changes in intestinal permeability in cirrhosis are associated with mucosal bacteria
18. Lactobacillus protects against leaky gut, future decompensation, and hepatic encephalopathy in patients with cirrhosis
19. 257 - The Human Microbiome
20. Clostridioides difficile infection surveillance in intensive care units and oncology wards using machine learning
21. The Gut Microbiome Modulates Body Temperature Both in Sepsis and Health
22. Vaginal microbiota of adolescents and their mothers: A preliminary study of vertical transmission and persistence
23. A Predictive Model to Identify Complicated Clostridiodes difficile Infection
24. Virulence and genomic diversity among clinical isolates of ST1 (BI/NAP1/027)Clostridioides difficile
25. Microbiome therapeutics for the treatment of recurrent Clostridioides difficile infection
26. Prospective evaluation of data-driven models to predict daily risk of Clostridioides difficile infection at 2 large academic health centers – ERRATUM
27. Distinct stimulus-dependent neutrophil dynamics revealed by real-time imaging of intestinal mucosa after acute injury
28. Human neutrophil IL1β directs intestinal epithelial cell extrusion during Salmonella infection
29. Clostridioides difficileinfection surveillance in intensive care units and oncology wards using machine learning
30. The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity
31. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis
32. Neutrophils prime unique transcriptional responses in intestinal organoids during infection with nontyphoidal Salmonella enterica serovars
33. Author Reply to Peer Reviews of Human neutrophils direct epithelial cell extrusion to enhance intestinal epithelial host defense during Salmonella infection
34. Duodenal permeability is associated with mucosal microbiota in compensated cirrhosis
35. A Predictive Model to Identify Complicated Clostridiodes difficile Infection
36. Differences in Gut Microbiota Assembly Alter Its Ability to Metabolize Dietary Polysaccharides and Resist Clostridioides difficile Colonization
37. Viewing Bacterial Colonization through the Lens of Systems Biology
38. Human neutrophils direct epithelial cell extrusion to enhance intestinal epithelial host defense during Salmonella infection
39. Tu1777 QUIESCENT CROHN'S DISEASE PATIENTS WITH PERSISTENT SYMPTOMS SHOW ENRICHMENT OF SULFUR METABOLITES AND SULFUR METABOLIC PATHWAYS
40. Prospective evaluation of data-driven models to predict daily risk of Clostridioides difficileinfection at 2 large academic health centers
41. Structure and function of the human microbiome: implications for health and disease
42. Perfusion System for Modification of Luminal Contents of Human Intestinal Organoids and Realtime Imaging Analysis of Microbial Populations
43. Microbiome therapeutics for hepatic encephalopathy
44. Contributors
45. 17. Comparative Assessment of a Machine Learning Model and Rectal Swab Surveillance to Predict Hospital Onset Clostridioides difficile
46. Microbiome therapeutics for the treatment of recurrent Clostridioides difficileinfection
47. Longitudinal genomic surveillance of carriage and transmission of Clostridioides difficilein an intensive care unit
48. External Validation and Comparison of Clostridioides difficile Severity Scoring Systems.
49. OS-019 - Lactobacillus protects against leaky gut, future decompensation, and hepatic encephalopathy in patients with cirrhosis
50. Tu1881 THE MICROBIOME IN QUIESCENT CROHN'S DISEASE PATIENTS WITH PERSISTENT SYMPTOMS IS SIMILAR TO ACTIVE CROHN'S DISEASE BUT SIGNIFICANTLY DIFFERENT FROM QUIESCENT CROHN'S DISEASE PATIENTS WITHOUT SYMPTOMS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.